Centre for Commercialization of Regenerative Medicine

Eligibility criteria for this grant:

• Applicants must be companies operating at the interface between academia and industry.
• Projects must involve manufacturing challenges in areas like process development, analytics, and commercial GMP-compliant manufacturing.
• Preference given to projects in cell and gene therapies, with a focus on advancing therapies towards the clinic.

Who is eligible?

The context provided does not detail specific eligibility criteria for a grant application directly related to CCRM's services. However, typically, the type of entities that may be interested in reaching out or exploring collaboration with CCRM include companies or research entities at the interface of academia and industry that are focused on cell and gene therapy manufacturing, require process development, and are aiming to transition from pre-clinical to GMP-compliant manufacturing stages. These may include small biotechs, large pharmaceutical companies, or research organizations involved in developing innovative therapies. Prospective partners are likely engaged in:- Manufacturing challenges needing technical support or solutions.- Cell and gene therapy development.- Seeking to scale from pre-clinical to commercial manufacturing.- Engaging in collaborative processes for technological and manufacturing development.- Needing infrastructure and resources for GMP-compliance and process continuity from lab to market.

Eligible expenses

The activities eligible for this grant are focused on addressing manufacturing challenges and advancing manufacturing processes for cell and gene therapies. This involves collaboration and utilization of specialized infrastructure and technologies to streamline production and ensure compliance with industry standards.

• Tackling manufacturing challenges at the interface between academia and industry.
• Accessing process development and analytics services for cell and gene therapies.
• Availing pre-clinical to commercial GMP-compliant manufacturing services.
• Collaborating with an industry-leading team, including 55+ PhDs, for specialized expertise.
• Using enabling technologies through industry partnerships for advanced manufacturing solutions.

There are evaluation and selection criteria for this grant. The criteria include:

• Technical expertise and alignment with project goals
• Demonstrated collaborative approach to problem-solving
• Potential for successful process development and manufacturing
• Track record of delivering complex projects on time and on budget

Here are additional relevant details for this grant:

• The collaboration with CCRM provides access to 55+ PhDs, ensuring significant specialized expertise to support projects.
• CCRM boasts state-of-the-art facilities that are accessible for remote viewing, which can provide potential applicants with an insight into the possibilities for their projects.
• CCRM has a strong track record, having supported three IND filings since 2019, indicating a proven capacity to aid in regulatory processes.
• The collaboration with CCRM includes co-located process development and GMP-compliant manufacturing, ensuring seamless transition and process continuity from lab development to full-scale production.
• Customer testimonials showcase successful collaborations, reflecting CCRM's effectiveness in improving manufacturing timelines and processes.